相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New perspectives: glioma in adult patients
Antonio Silvani
TUMORI JOURNAL (2023)
Quality of life in patients with glioblastoma and their relatives
Pernilla Stahl et al.
ACTA NEUROLOGICA SCANDINAVICA (2022)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2022)
Targeting post-translational histone modifying enzymes in glioblastoma
Elena Kunadis et al.
PHARMACOLOGY & THERAPEUTICS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Novel Therapies for Glioblastoma
Elisa K. Liu et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells
Logeswari Ponnusamy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Ten-year survival in glioblastoma. A systematic review
Tomasz Tykocki et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
Mikkel Staberg et al.
CELLULAR ONCOLOGY (2017)
Functional network analysis of gene-phenotype connectivity associated with temozolomide
Jia Shi et al.
ONCOTARGET (2017)
Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression
Fengming Lan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide
Jose L. McFaline-Figueroa et al.
CANCER RESEARCH (2015)
Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells
Gisela Natalia Castro et al.
CELL STRESS & CHAPERONES (2015)
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
Gloria Perazzoli et al.
PLOS ONE (2015)
Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Bircan Savran et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma
Yoshinari Shinsato et al.
ONCOTARGET (2013)
DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells
Chun-Feng Meng et al.
MOLECULAR MEDICINE REPORTS (2011)
Role of Histone Modifications and DNA Methylation in the Regulation of O6-Methylguanine-DNA Methyltransferase Gene Expression in Human Stomach Cancer Cells
Chun-Feng Meng et al.
CANCER INVESTIGATION (2010)
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cells
Patrick Imesch et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J. Kitange et al.
NEURO-ONCOLOGY (2009)
Attenuated DNA damage repair by trichostatin a through BRCA1 suppression
Yin Zhang et al.
RADIATION RESEARCH (2007)
Contributing factors of temozolomide resistance in MCF-7 tumor xenograft models
Yoshinori Kato et al.
CANCER BIOLOGY & THERAPY (2007)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer
Y Kondo et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Regulation of the human O6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300
KK Bhakat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
